Matthew Andrews

Stock Analyst at Jefferies

(1.87)

# 1,806

Out of 4,497 analysts

4

Total ratings

100%

Success rate

39.73%

Average return

Main Sectors:

Top Industries:

2 Stocks

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	TGTX TG Therapeutics	Maintains: Buy	n/a	$21.00	-	2	Nov 1, 2023
	CARA Cara Therapeutics	Assumes: Buy	n/a	$0.34	-	2	Feb 6, 2019

TG Therapeutics

Nov 1, 2023

Maintains: Buy

Price Target: n/a

Current: $21.00

Upside: -

Cara Therapeutics

Feb 6, 2019

Assumes: Buy

Price Target: n/a

Current: $0.34

Upside: -